Q2 solutions   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Morrisville NC United States (2015)
Status: Acquired by IQVIA (2021)

Organization Overview

First Clinical Trial
2015
NCT01593254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Q2 Solutions | Q2 Solutions, LLC | Q Square Solutions

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Breast Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 1)

Diabetes Mellitus, Type 2 (Phase 3)

Glomerulonephritis (Phase 2)

Glomerulonephritis, Membranous (Phase 2)

Hemophilia A (Phase 3)

Influenza, Human (Phase 3)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Psoriasis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 25